BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11435248)

  • 1. Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants.
    Zhu J; Qiu YS; Majumdar S; Gamble E; Matin D; Turato G; Fabbri LM; Barnes N; Saetta M; Jeffery PK
    Am J Respir Crit Care Med; 2001 Jul; 164(1):109-16. PubMed ID: 11435248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.
    Ma L; Zhu M; Li G; Gai J; Li Y; Gu H; Qiao P; Li X; Ji W; Zhao R; Wu Y; Wan Y
    Respir Res; 2022 Nov; 23(1):316. PubMed ID: 36403040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
    Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
    J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Inflammatory Effects of Diospyrin on Lipopolysaccharide-Induced Inflammation Using RAW 264.7 Mouse Macrophages.
    Shahidullah A; Lee JY; Kim YJ; Halimi SMA; Rauf A; Kim HJ; Kim BY; Park W
    Biomedicines; 2020 Jan; 8(1):. PubMed ID: 31940845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction increases pro-inflammatory cytokine production and impairs repair and corticosteroid responsiveness in lung epithelium.
    Hoffmann RF; Jonker MR; Brandenburg SM; de Bruin HG; Ten Hacken NHT; van Oosterhout AJM; Heijink IH
    Sci Rep; 2019 Oct; 9(1):15047. PubMed ID: 31636329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease.
    Tinè M; Biondini D; Semenzato U; Bazzan E; Cosio MG; Saetta M; Turato G
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31269773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Count of Eosinophil Polymorphonuclear Leucocytes and Bronchial Hyperreactivity in Chronic Obstructive Pulmonary Disease.
    Cukic V
    Med Arch; 2017 Oct; 71(5):347-350. PubMed ID: 29284904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?
    Brandsma CA; de Vries M; Costa R; Woldhuis RR; Königshoff M; Timens W
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29212834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic biomarkers for detection of acute exacerbation of chronic obstructive pulmonary disease with or without pulmonary embolism.
    Yang QF; Lu TT; Shu CM; Feng LF; Chang HT; Ji QY
    Exp Ther Med; 2017 Oct; 14(4):3198-3206. PubMed ID: 28912870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma and chronic obstructive pulmonary disease overlap syndrome: An update.
    Lu M; Yao WZ
    J Transl Int Med; 2015; 3(4):144-146. PubMed ID: 27847903
    [No Abstract]   [Full Text] [Related]  

  • 11. Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Anzueto A; Miravitlles M; Arvis P; Alder J; Haverstock D; Trajanovic M; Wilson R
    Infection; 2016 Feb; 44(1):65-76. PubMed ID: 26370552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between decrease of CRP and resolution of airway inflammatory response, improvement of health status, and clinical outcomes during severe acute exacerbation of chronic obstructive pulmonary disease.
    Liang Y; Chang C; Zhu H; Shen N; He B; Yao W
    Intern Emerg Med; 2015 Sep; 10(6):685-91. PubMed ID: 25822151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine inhibition in the treatment of COPD.
    Caramori G; Adcock IM; Di Stefano A; Chung KF
    Int J Chron Obstruct Pulmon Dis; 2014; 9():397-412. PubMed ID: 24812504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of the microbiome in chronic obstructive pulmonary disease.
    Martinez FJ; Erb-Downward JR; Huffnagle GB
    Ann Am Thorac Soc; 2013 Dec; 10 Suppl(Suppl):S170-9. PubMed ID: 24313769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary biomarkers in COPD exacerbations: a systematic review.
    Koutsokera A; Kostikas K; Nicod LP; Fitting JW
    Respir Res; 2013 Oct; 14(1):111. PubMed ID: 24143945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.
    Matera MG; Calzetta L; Cazzola M
    Drugs; 2013 Oct; 73(15):1653-63. PubMed ID: 24127222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.
    Shafiek HA; Abd-Elwahab NH; Baddour MM; El-Hoffy MM; Degady AA; Khalil YM
    ISRN Microbiol; 2012; 2012():240841. PubMed ID: 23724320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The overlap phenotype: the (missing) link between asthma and COPD.
    Piras B; Miravitlles M
    Multidiscip Respir Med; 2012 Jun; 7(1):8. PubMed ID: 22958436
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of exacerbations on COPD.
    Anzueto A
    Eur Respir Rev; 2010 Jun; 19(116):113-8. PubMed ID: 20956179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap Between Asthma and COPD: Where the Two Diseases Converge.
    Kim SR; Rhee YK
    Allergy Asthma Immunol Res; 2010 Oct; 2(4):209-14. PubMed ID: 20885905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.